Arbutus Biopharma Aktie
3,31
EUR
-0,17
EUR
-4,99
%
3,94
USD
-0,23
USD
-5,52
%
Werbung
Arbutus Biopharma Aktie Analyse
| 15.10.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 06.07.18 | Arbutus Biopharma Neutral | B. Riley FBR, Inc. | |
| 19.03.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 13.12.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 14.10.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 16.06.16 | Arbutus Biopharma Neutral | Chardan Capital Markets |
Werbung
Werbung